The uptick in Leqembi (lecanemab) sales comes a few months after the FDA approved a once-weekly subcutaneous injection ...

Bayer is vying to be first to market in the oral Factor XIa category against Bristol Myers Squibb and Johnson & Johnson, ...

Incubated by Flagship Pioneering, Generate applies AI to teasing out the three-dimensional structure of human proteins, ...

Telehealth company GoodRx said it is a "core integration partner" for TrumpRx, providing access to around 30 of Pfizer's ...

Pharma digital success is still largely defined by top level engagement metrics such as page visits, time on page, and ...

Sam Possemiers, CEO of MRM Health, believes that the space is finally coming into maturity. At his own company, that’s in the ...

On Amgen's call, the company's head of R&D, Jay Bradner, said the FDA's request for a voluntary withdrawal on 16th January ...

A wireless sensor the size of a paperclip, Abbott's CardioMEMS HF, can be used routinely by the NHS to monitor patients with ...

Galleri is a multi-cancer early detection (MCED) or 'liquid biopsy' test that Grail says can spot signs of up to 50 different ...

European biotechs continue to face a demanding investment climate characterised by investor caution. As a result, many are ...

Phase 2 results in advanced pancreatic cancer were presented at last year's ASCO cancer congress, and the live ...

Luke Miels' first financial results since taking over as chief executive of GSK revealed a jump in sales and profits, fuelled ...